Sangart, Inc.
Records under this name other than the patents Sangart, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,821,158 | Polyalkylene oxide valerate hemoglobin conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,029,001 | Diaspirin Crosslinked Pegylated Hemoglobin Formerly held Lapsed on the fee record Ended Jul 24, 2026 · High confidence | Lapsed on the fee record | Ended Jul 24, 2026 | High confidence |
| US 11,359,004 | Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins Formerly held Lapsed on the fee record Ended Jun 14, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2026 | From the USPTO record |
| US 7,622,439 | Method to enhance hemodynamic stability using oxygen carrying compositions Term ended Term ended Aug 31, 2025 · From the USPTO record | Term ended | Term ended Aug 31, 2025 | From the USPTO record |
| US 8,278,275 | Method to enhance hemodynamic stability using oxygen carrying compositions Lapsed on the fee record Ended Oct 2, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 2, 2024 | From the USPTO record |
| US 7,271,145 | Methods and compositions for oxygen transport comprising modified hemoglobin in plasma Term ended Term ended Nov 5, 2023 · From the USPTO record | Term ended | Term ended Nov 5, 2023 | From the USPTO record |
| US 9,138,464 | MalPEG Hb conjugate-containing compositions for delivering nitric oxide (NO) to cells Lapsed on the fee record Ended Sep 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | From the USPTO record |
| US 8,021,858 | Method for making polyalkylene oxide modified hemoglobin Lapsed on the fee record Ended Sep 20, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2023 | From the USPTO record |
| US 6,974,795 | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin Term ended Term ended Sep 11, 2022 · From the USPTO record | Term ended | Term ended Sep 11, 2022 | From the USPTO record |
| US 7,625,862 | Method for making a high oxygen affinity modified hemoglobin for oxygen transport Term ended Term ended Aug 27, 2022 · From the USPTO record | Term ended | Term ended Aug 27, 2022 | From the USPTO record |